Origin of blood-group antigens: A self-declaration mechanism in somatic cell society

Medical Hypotheses

Volumn 46, Issue 3, 1996, Pages 290-294

  Chigira, M ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN;

ANTIGEN RECOGNITION; BLOOD GROUP; CELL DIFFERENTIATION; HOMEOSTASIS; HUMAN; HYPOTHESIS; PRIORITY JOURNAL; REVIEW; SOMATIC CELL;

EID: 0029873501     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90258-3     Document Type: Article

References (84)

1. Evans E E. Antibody response in amphibia and reptilia. Fed Proc 1963; 22: 1132-1137.
2. Linthicum D S, Hildemann W H. Immunological responses of pacific hagfish. III. Serum antibodies to cellular antigens. J Immunol 1970; 105: 912-918.
3. Diener E, Matchalonis J J. Cellular and humoral aspects of the primary response of the toad, Bufo marius. Immunol 1970; 18: 279-293.
4. Hakkinen I. A-like blood group antigen in gastric cancer cells of patients in blood groups O or B. J Natl Cancer Inst 1970; 44: 1183-1188.
5. Clausen H, Hakomori S, Graem N, Dabelsteen E. Incompatible A antigen expressed in tumors of blood group O individuals: immunochemical, immunohistologic, and enzymatic characterization. J Immunol 1986; 136: 326-330.
6. Lee J S, Ro J Y, Sahin A A et al. Expression of blood-group antigen A: a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 1991; 324: 1084-1090.
7. Matsui T, Shimano S, Furukawa K. Altered expression of blood group A and H antigens on red cells from an acute leukemic patient. Exp Clin Immunogenet 1992; 9: 125-129.
8. b antigens with survival in patients with carcinoma of the lung. N Engl J Med 1992; 327: 14-18.
9. Chigira M, Shinozaki T, Watanabe H. Theoretical basis of paraneoplastic autoimmune disorders. Oncol Rep 1995; 2: 397-415.
10. Chigira M, Watanabe H. Non-teleological differentiation of malignancy. Oncol Rep 1994; 1: 329-339.
11. Lutz H U. Naturally occurring anti-band 3 antibodies. Transfus Med Rev 1992; 6: 201-211.
12. Owen I, Chowdhury V, Reid M E, Poole J, Marsh J C, Hows J M. autoimmune hemolytic anemia associated with anti-Scl. Transfusion 1992; 32: 173-176.
13. Scott B B, Sadigh S, Stow M, Mageed R A, Andrew E M, Maini R N. Molecular mechanisms resulting in pathogenic anti-mouse erythrocyte antibodies in New Zealand black mice. Immunol 1993; 93: 26-33.
14. Barker R N, Oliveira G G, Elson C J, Lydyard P M. Pathogenic autoantibodies in the NZB mouse are specific for erythrocyte band 3 protein. Eur J Immunol 1993; 23: 1723-1726.
15. Young J L, Hooper D C. Characterization of autoreactive helper T cells in a murine model of autoimmune haemolytic disease. Immunol 1993; 80: 13-21.
16. Leddy J P, Wilkinson S L, Kissel G E, Passador S T, Falany J L, Rosenfeld S I. Erythrocyte membrane proteins reactive with IgG (warm-reacting) anti-red blood cell autoantibodies: II. Antibodies coprecipitating ban 3 and glycophorin A. Blood 1994; 84: 650-656.
17. Balding P, Gold E R. The natural heterohaemagglutinin in the serum of the toad Bufo regularis, and its relationship to lower vertebrate immunoglobulins. Immunol 1976; 30: 769-777.
18. Zaborski P. H-Y antigen in nonmammalian vertebrates. Arch Anat Microsc Morphol Exp 1985; 74: 33-37.
19. Abe K, Levery S B, Hakomori S. The antibody specific to type 1 chain blood group A determinant. J Immunol 1984; 132: 1951-1954.
20. Meldgaad P, Holmes E H, Bennett E P et al. Blood group ABO-related glycosylation of urothelial cell lines: Immunocytological, enzymatic, and genetic characterization. Cancer Res 1994; 54: 2440-2447.
21. b and Y antigens in colorectal tumors. Jpn J Cancer Res 1993; 84: 989-995.
22. Chigira M. Freedom from wholism in multicellular organisms: A possible role of tumor suppressor genes. Med Hypotheses 1991; 36: 146-151.
23. Chigira M. Selfish cells in altruistic cell society: theoretical oncology. Int J Oncol 1993; 3: 441-455.
24. Chigira M. A general model of carcinogenesis (I): Tumor evolution and gene deletion. Med Hypotheses 1993; 40: 223-226.
25. Hakomori S. Tumor associated carbohydrate antigens. Ann Rev Immunol 1984; 2: 103-126.
26. Hakomori S, Nudelman E, Levery S B, Kannagi R. Novel fucolipids accumulating in human adenocarcinoma 1. Glycolipids with di- or trifucosylated type 2 chain. J Biol Chem 1984; 259: 4672-4680.
27. Fukushi Y, Hakomori S, Nudelman E, Cochran N. Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognized mono-, di-, or trifucosylated type 2 chain. J Biol Chem 1984; 259: 4681-4685.
28. Hakomori S. Glycosphingolipids. Sci Am 1986; 254: 32-41.
29. Hakomori S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Ann Rev Biochem 1981; 50: 733-764.
30. Artzt K, Dubois P, Bennett D, Condamine H, Babinet C, Jacob F. Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture. Proc Natl Acad Sci USA 1973; 70: 2988-2992.
31. Jacob F. Mouse teratocarcinoma and embryonic antigens. Immunol Rev 1977; 33: 3-32.
32. Kemler R, Babinet C, Eisen H, Jacob F. Surface antigen in early differentiation. Proc Natl Acad Sci USA 1977; 74: 4449-4452.
33. Muramatsu T, Gachelin G, Damonneville M, Delarbre C, Jacob F. Cell surface carbohydrates of embryonal carcinoma cells: polysaccharidic side chains of F9 antigens and of receptors to two lectins, FBP and PNA. Cell 1979; 18: 183-191.
34. Mummery C L, Feyen A, Freund D, Shen S. Characteristics of embryonic stem cell differentiation: a comparison with two embryonal carcinoma cell lines. Cell Differ Develop 1990; 30: 195-206.
35. + double-negative, cytotoxic T lymphocytes. Jpn J Cancer Res 1993; 84: 58-64.
36. Kannagi R, Nudelman E, Levery S B, Hakomori S. A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to developmentally-regulated antigen, SSEA-1. J Biol Chem 1982; 257: 14865-14874.
37. Miyake M, Zenita K, Tanaka O, Okada Y, Kannagi R. Stage-specific expression of SSEA-1-related antigens in the developing lung of human embryos and its relation to the distribution of these antigens in lung cancers. Cancer Res 1988; 48: 7150-7158.
38. Chigira M. Self and nonself: duality of immune system. Med Hypotheses 1994; 43: 6-10.
39. Telen M J. Erythrocyte blood group antigens: not so simple after all. Blood 1995; 85: 299-306.
40. Watchtel S S. Immunogenetic aspects of abnormal sexual differentiation. Cell 1979; 16: 691-695.
41. Wachtel S S. The genetics of intersexuality: cinical and theoretical perspectives. Obstet Gynecol 1979; 54: 671-685.
42. Silvers W K, Watchtel S S. H-Y antigen: behavior and function. Science 1977; 195: 956-960.
43. Meck J M. The genetics of the H-Y antigen system and its role in sex determination. Perspect Biol Med 1984; 27: 560-584.
44. Lau Y F, Chan K M, Sparkes R. Male-enhanced antigen gene is phylogenetically conserved and expressed at late sates of spermatogenesis. Proc Natl Acad Sci USA 1989; 86: 8462-8466.
45. Hakomori S. Bifunctional role of glycosphingolipids: modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 1990; 256: 18713-18716.
46. Hakomori S. Possible functions of tumor-associated carbohydrate antigens. Curr Opin Immunol 1991; 3: 646-653.
47. Hakomori S. Structure and function of sphingoglycolipids in transmembrane signaling and cell-cell interactions. Biochem Soc Transact 1993; 21: 583-595.
48. Hakomori S, Igarashi Y. Gangliosides and glycosphingolipids as modulators of cell growth, adhesion, and transmembrane signaling. Adv Lipid Res 1993; 25: 147-162.
49. Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Develop 1988; 102: 639-655.
50. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Ann Rev Biochem 1990; 59: 237-252.
51. Takeichi M. Cadherin: cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-1455.
52. Shapiro L, Fannon A M, Kwong P D et al. Structural basis of cell-cell adhesion by cadherins. Nature 1995; 374: 327-337.
53. Holt C E, Lemaire O, Gurdon J B. Cadherin-mediated cell interactions are necessary for the activation of myoD in Xenopus mesoderm. Proc Natl Acad Sci USA 1994; 91: 10844-10848.
54. Takeda A, Ohmori K, Takahashi N et al. Adhesion of human cancer cells to vascular endothelium mediated by carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun 1991; 179: 713-719.
55. Komano H, Mizuno D, Natori S. Purification of lectin induced in the hemolymph of Sarcophaga peregrina larvae on injury. J Biol Chem 1980; 255: 2919-2924.
56. Natori S. Dual functions of insect immunity protein in defence and development. Res Immunol 1990; 141: 938-939.
57. Nagasawa Y, Kurata S, Komano H, Natori S. Purification and heterogenous localization of Sarcophaga lectin receptor on the surface of imaginal discs of Sarcophaga peregrina (flesh fly). Dvelop Growth Differ 1993; 35: 331-340.
58. Homma K, Kurata S, Natori S. Purification, characterization, and cDNA cloning of procathepsin L from the culture medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina (flesh fly), and its involvement in the differentiation of imaginai discs. J Biol Chem 1994; 269: 15258-15264.
59. Miyata T, Hiranaga M, Umezu M, Iwanaga S. Amino acid sequence of the coagulogen from Limulus polyphemus hemocytes. J Biol Chem 1984; 259: 8924-8933.
60. Miyata T, Matsumoto H, Hattori M, Sakaki Y, Iwanaga S. Two types of coagulogen mRNAs found in horseshoe crab (Tachypleus tridentatus) hemocytes: molecular cloning and nucleotide sequences. J Biochem 1986; 100: 213-220.
61. Fortes-Dias C L, Minetti C A S, Lin Y, Liu T Y. Agglutination activity of Limulus polyphemus coagulogen following limited proteolysis. Comp Biochem Physiol 1993; 105B: 79-85.
62. Liu T Y, Minetti CAS, Fortes-Dias C L, Liu T, Lin L, Lin Y. C-reactive proteins, limunectin, lipopolysaccharide-binding protein, and coagulin. Ann New York Acad Sci 1994; 712: 146-154.
63. Schluter S F, Schroeder J, Wang E, Marchalonis J J. Recognition molecules and immunoglobulin domains in invertebrates. Ann New York Acad Sci 1994; 712: 74-81.
64. Vasta G R, Ahmed H, Fink N E. Animal lectins as self/non-self recognition molecules: biochemical and genetic approaches to understanding their biological roles and evolution. Ann New York Acad Sci 1994; 712: 55-73.
65. Sharon N, Lis H. Lectins as cell recognition molecules. Science 1989; 246: 227-234.
66. Sharon N, Lis H. Carbohydrates in cell recognition. Sci Am 1993; 268: 74-81.
67. Chigira M, Watanabe H. Differentiation as symbiosis. Med Hypotheses 1994; 43: 17-18.
68. Nicholson-Weller A, March J P, Rosenfeld S I, Austen K F. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci USA 1983; 80: 5066-5070.
69. Pangburn M K, Schreiber R D, Muller-Eberhard H J. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA 1983; 80: 5430-5434.
70. Holguin M H, Wilcox L A, Bernshaw N J, Rosse W F, Parker C J. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 1989; 84: 1387-1394.
71. Rosse W F. Paroxysmal nocturnal hemoglobinuria: the biochemical defects and the clinical syndrome. Blood Rev 1989; 3: 192-200.
72. Miyata T, Takeda J, Iida Y et al. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 1993; 259: 1318-1320.
73. Lublin D M, Atkinson J P. Decay-accelerating factor: biochemistry molecular biology, and function. Ann Rev Immunol 1989; 7: 35-58.
74. Yamashita M, Ueda E, Kinoshita T et al. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1990; 323: 1184-1189.
75. Holguin M H, Parker C J. Membrane inhibitor of reactive lysis. Curr Top Microbiol Immunol 1992; 178: 61-85.
76. Ljunggren H G, Karre K. In search of the 'missing self: MHC molecules and NK cell recognition. Immunol Today 1990; 11:237-244.
77. Karre K. Express yourself or die: peptides, MHC molecules, and NK cells. Science 1995; 267: 978-979.
78. Moretta L, Ciconne E, Mingari M C, Biassoni R, Moretta A. Human natural killer cells: origin, clonality, specificity, and receptors. Adv Immunol 1994; 55: 341-380.
79. Malnati M S, Peruzzi M, Parker K C et al. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 1995; 267: 1016-1018.
80. Hall. Genomic imprinting: review and relevance to human diseases. Am J Human Genet 1990; 46: 857-873.
81. Stewart C L. Genomic imprinting in the regulation of mammalian development. Adv Develop Biol 1993; 2: 73-118.
82. Feinberg A P. Genomic imprinting and gene activation in cancer. Nature Genet 1993; 4: 110-113.
83. Dawkins R. The selfish gene. Oxford: Oxford University Press, 1976.
84. Dawkins R. The extended phenotypes: the gene as the unit of selection. Oxford: Oxford University Press, 1982.